89 research outputs found

    The Upconversion Luminescence of Ca3Sc2Si3O12:Yb3+,Er3+ and Its Application in Thermometry

    Get PDF
    To develop novel luminescent materials for optical temperature measurement, a series of Yb3+- and Er3+-doped Ca3Sc2Si3O12 (CSS) upconversion (UC) phosphors were synthesized by the sol– gel combustion method. The crystal structure, phase purity, and element distribution of the samples were characterized by powder X-ray diffraction and a transmission electron microscope (TEM). The detailed study of the photoluminescence emission spectra of the samples shows that the addition of Yb3+ can greatly enhance the emission of Er3+ by effective energy transfer. The prepared Yb3+ and Er3+ co-doped CSS phosphors exhibit green emission bands near 522 and 555 nm and red emission bands near 658 nm, which correspond to the 2H11/2→4 I15/2, 4S3/2→4 I15/2, and 4F9/2→4 I15/2 transitions of Er3+, respectively. The temperature-dependent behavior of the CSS:0.2Yb3+,0.02Er3+ sample was carefully studied by the fluorescence intensity ratio (FIR) technique. The results indicate the excellent sensitivity of the sample, with a maximum absolute sensitivity of 0.67% K−1 at 500 K and a relative sensitivity of 1.34% K−1 at 300 K. We demonstrate here that the temperature measurement performance of FIR technology using the CSS:Yb3+,Er3+ phosphor is not inferior to that of infrared thermal imaging thermometers. Therefore, CSS:Yb3+,Er3+ phosphors have great potential applications in the field of optical thermometry

    Investigations into the characteristics and influences of nonequilibrium evolution

    Full text link
    In order to estimate qualitatively the influence of nonequilibrium evolution in relativistic heavy ion collisions, we use the three dimensional Ising model with Metropolis algorithm to study the evolution from nonequilibrium to equilibrium on the phase boundary. The evolution of order parameter approaches its equilibrium value exponentially, the same as that given by Langevin equation. The average relaxation time is defined which is demonstrated to well represent the relaxation time in dynamical equations. It is shown that the average relaxation time at critical temperature diverges as the zth power of system size. The third and the fourth cumulants of order parameter during the nonequilibrium evolution could be either positive or negative, depending on the observation time, consistent with dynamical models at T > Tc. It is found that the nonequilibrium evolution at T > Tc lasts very short, and the influence is weaker than that at T < Tc. Those qualitative features are instructive to determine experimentally the critical point and the phase boundary of QCD.Comment: 8 pages, 5 figures; add fig.3 and up date the eq.(9-10), and content

    Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids

    Get PDF
    IntroductionNon-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported.MethodsTherefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD.ResultsThe changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera Blautia, Lactobacillus, Allobaculum, Lachnoclostridium and Bacteroides were predominant in the NAFLD group, whereas, Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum, and Psychrobacter were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman’s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1, and Turicibacter, which were also significantly correlated with the biological parameters of NAFLD.DiscussionTaken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids

    LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473

    Get PDF
    Multiple myeloma (MM) is a highly heterogeneous hematological malignancy originating from B lymphocytes, with a high recurrence rate primarily due to drug resistance. 2-((1H-indol-3-yl)methyl)-3-((3-((1H-indol-3-yl)methyl)-1H-indol-2-yl)methyl)-1H-indole (LTe2), a tetrameric indole oligomer, possesses a wide range of anticancer activities through various mechanisms. Here, we aim to explore the anti-tumor efficiency and potential downstream targets of LTe2 in MM. Its bioactivity was assessed by employing MTT assays, flow cytometry, and the 5TMM3VT mouse model. Additionally, transcriptomic RNA-seq analysis and molecular dynamics (MD) experiments were conducted to elucidate the mechanism underlying LTe2 induced MM cell apoptosis. The results demonstrated that LTe2 significantly inhibited MM cell proliferation both in vitro and in vivo, and revealed that LTe2 exerts its effect by inhibiting the phosphorylation of AKT at the Thr308 and Ser473 sites. In summary, our findings highlight the potential of LTe2 as a novel candidate drug for MM treatment and provided a solid foundation for future clinical trials involving LTe2
    corecore